168 related articles for article (PubMed ID: 1422570)
21. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
Lu JF; Chen G; Xiang BR; An DK
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
[TBL] [Abstract][Full Text] [Related]
22. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
[TBL] [Abstract][Full Text] [Related]
23. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
[TBL] [Abstract][Full Text] [Related]
24. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
Berg AK; Myrvik MJ; Van Ess PJ
Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
[TBL] [Abstract][Full Text] [Related]
30. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
Tuk B; Herben VM; Mandema JW; Danhof M
J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
[TBL] [Abstract][Full Text] [Related]
31. Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: a population pharmacokinetic model.
Jauregizar N; Quintana A; Suarez E; Raczka E; de la Fuente L; Calvo R
Gerontology; 2003; 49(4):205-14. PubMed ID: 12792155
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
[TBL] [Abstract][Full Text] [Related]
33. Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women.
Vanakoski J; Strömberg C; Seppälä T
Eur J Clin Pharmacol; 1993; 45(4):377-81. PubMed ID: 8299674
[TBL] [Abstract][Full Text] [Related]
34. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
[TBL] [Abstract][Full Text] [Related]
35. The influence of dosage time of midazolam on its pharmacokinetics and effects in humans.
Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
Clin Pharmacol Ther; 1991 Jul; 50(1):16-24. PubMed ID: 1855349
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity.
Van Steveninck AL; Mandema JW; Tuk B; Van Dijk JG; Schoemaker HC; Danhof M; Cohen AF
Br J Clin Pharmacol; 1993 Aug; 36(2):109-15. PubMed ID: 8398578
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.
Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
Clin Pharmacol Ther; 1988 Jul; 44(1):14-22. PubMed ID: 3391000
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.
Lau CE; Ma F; Wang Y; Smith C
Psychopharmacology (Berl); 1996 Aug; 126(3):241-8. PubMed ID: 8876024
[TBL] [Abstract][Full Text] [Related]
39. Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam.
Jacobs JR; Reves JG; Marty J; White WD; Bai SA; Smith LR
Anesth Analg; 1995 Jan; 80(1):143-8. PubMed ID: 7802272
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
